The Circadian Clock Protein CRY1 Is a Negative Regulator of HIF-1α

Area of Science:

• Molecular Biology
• Cellular Biology
• Cancer Research

Background:

• The circadian clock and hypoxia signaling are crucial for cellular homeostasis.
• Dysregulation of these pathways is implicated in diseases like cancer.
• The interplay between circadian regulators and hypoxia-inducible factors (HIFs) is not fully understood.

Purpose of the Study:

• To investigate the role of the circadian regulator CRY1 in the hypoxia-signaling pathway.
• To elucidate the molecular mechanism by which CRY1 affects HIF activity.
• To explore the implications of CRY1-HIF interaction in cellular processes relevant to carcinogenesis.

Main Methods:

• Investigated CRY1 interaction with HIF-1α using co-immunoprecipitation and domain mapping.
• Assessed the effect of CRY1 on HIF-1α protein stability and promoter binding.
• Utilized genetic disruption of CRY1 (CRISPR/Cas9, shRNA) and assessed cellular phenotypes (proliferation, migration) and HIF levels.
• Examined the specificity of CRY1's role by comparing with CRY2.

Main Results:

• CRY1 directly interacts with HIF-1α, reducing its half-life and promoter binding.
• Genetic disruption of CRY1, but not CRY2, significantly impacts the hypoxia response.
• CRY1 deficiency leads to elevated cellular HIF levels, increased proliferation, and migration.
• HIF knockout reversed the pro-proliferative and migratory effects observed in CRY1-deficient cells.

Conclusions:

• CRY1 acts as a negative regulator of the hypoxia-signaling pathway by targeting HIF-1α.
• This study provides a mechanistic link between circadian clock disruption and hypoxia-driven processes.
• Findings offer insights into the molecular basis of associations between circadian clock dysfunction and carcinogenesis.